메뉴 건너뛰기




Volumn , Issue , 2012, Pages 9-12

Anticancer drug sensitivity analysis: An integrated approach applied to Erlotinib sensitivity prediction in the CCLE database

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONAL BEHAVIORS; GENERATING FUNCTIONS; INDUSTRY COLLABORATION; INHIBITION PROFILE; INTEGRATED APPROACH; PREDICTION ACCURACY; PREDICTIVE MODELING; SENSITIVITY PREDICTION;

EID: 84877823775     PISSN: 21503001     EISSN: 2150301X     Source Type: Conference Proceeding    
DOI: 10.1109/GENSIPS.2012.6507714     Document Type: Conference Paper
Times cited : (7)

References (7)
  • 1
    • 84859169877 scopus 로고    scopus 로고
    • The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
    • Mar.
    • Jordi Barretina and et al., "The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.," Nature, vol. 483, no. 7391, pp. 603-607, Mar. 2012.
    • (2012) Nature , vol.483 , Issue.7391 , pp. 603-607
    • Barretina, J.1
  • 2
    • 67651006061 scopus 로고    scopus 로고
    • Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions
    • Martin L. Sos and et al., "Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.," The Journal of clinical investigation, vol. 119, no. 6, pp. 1727-1740, 2009.
    • (2009) The Journal of Clinical Investigation , vol.119 , Issue.6 , pp. 1727-1740
    • Sos, M.L.1
  • 3
    • 0035845531 scopus 로고    scopus 로고
    • Chemosensitivity prediction by transcriptional profiling
    • Jane E. Staunton and et al., "Chemosensitivity prediction by transcriptional profiling," Proceedings of The National Academy of Sciences, vol. 98, pp. 10787-10792, 2001.
    • (2001) Proceedings of the National Academy of Sciences , vol.98 , pp. 10787-10792
    • Staunton, J.E.1
  • 4
    • 84891424303 scopus 로고    scopus 로고
    • A kinase inhibition map approach for tumor sensitivity prediction and combination therapy design for targeted drugs
    • R. Pal and N. Berlow, "A kinase inhibition map approach for tumor sensitivity prediction and combination therapy design for targeted drugs," in Pacific Symposium on Biocomputing http://psb.stanford.edu/psbonline/ proceedings/psb12/pal.pdf, 2012, pp. 351-62.
    • (2012) Pacific Symposium on Biocomputing , pp. 351-362
    • Pal, R.1    Berlow, N.2
  • 5
    • 38049018155 scopus 로고    scopus 로고
    • A quantitative analysis of kinase inhibitor selectivity
    • January
    • Mazen W. Karaman and et al., "A quantitative analysis of kinase inhibitor selectivity.," Nature biotechnology, vol. 26, no. 1, pp. 127-132, January 2008.
    • (2008) Nature Biotechnology , vol.26 , Issue.1 , pp. 127-132
    • Karaman, M.W.1
  • 6
    • 70449475105 scopus 로고    scopus 로고
    • AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
    • Patrick P. Zarrinkar and et al., "AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)," Blood, vol. 114, no. 14, pp. 2984-2992, 2009.
    • (2009) Blood , vol.114 , Issue.14 , pp. 2984-2992
    • Zarrinkar, P.P.1
  • 7
    • 84877823406 scopus 로고    scopus 로고
    • Genetic and pharmacologic characterization of a large panel of human cancer cell lines
    • Broad-Novartis Cancer Cell Line Encyclopedia, "http://www. broadinstitute.org/ccle/home," Genetic and pharmacologic characterization of a large panel of human cancer cell lines.
    • Broad-Novartis Cancer Cell Line Encyclopedia


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.